Company Profile
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Latest News
Unpacking Q1 Earnings: Samsara (NYSE:IOT) In The Context Of Other Data Analytics Stocks
Health Catalyst, Commerce, and Paycom Shares Plummet, What You Need To Know
Health Catalyst Investors Approve Directors, Pay; Board Declassification Fails
3 Value Stocks with Open Questions
3 Reasons to Sell HCAT and 1 Stock to Buy Instead
| Sector | Healthcare |
| Industry | Health Information Services |
| Website | https://www.healthcatalyst.com |
| Audit Risk | 1 |
| Board Risk | 7 |
| Overall Risk | 7 |
| Market Cap | 153.70M |
| Forward P/E | 22.54 |
| Trailing Annual Div. Rate | 0 |
| Trailing Annual Div. Yield | 0.00% |
| Trailing EPS | -3.73 |
| Forward EPS | 0.09 |
| Book Value | 1.87 |
| Price-to-Book | 1.11 |
| Enterprise-to-Revenue | 0.71 |
| Enterprise-to-EBITDA | 249.66 |
| Short Ratio | 2.33 |
| Earnings Date | 08/06/2026 |
| Earnings Call Date | 05/11/2026 |
| Earnings Average | 0.03 |
| Earnings Low | 0.01 |
| Earnings High | 0.05 |
| Revenue Average | 68.94M |
| Revenue Low | 68.47M |
| Revenue High | 69.75M |